GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HAVN Life Sciences Inc (XCNQ:HAVN) » Definitions » Shares Outstanding (EOP)

HAVN Life Sciences (XCNQ:HAVN) Shares Outstanding (EOP) : 14.74 Mil (As of Jan. 2023)


View and export this data going back to 2020. Start your Free Trial

What is HAVN Life Sciences Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. HAVN Life Sciences's shares outstanding for the quarter that ended in Jan. 2023 was 14.74 Mil.

HAVN Life Sciences's quarterly shares outstanding increased from Oct. 2022 (8.47 Mil) to Jan. 2023 (14.74 Mil). It means HAVN Life Sciences issued new shares from Oct. 2022 to Jan. 2023 .

HAVN Life Sciences's annual shares outstanding increased from Apr. 2021 (3.59 Mil) to Apr. 2022 (5.09 Mil). It means HAVN Life Sciences issued new shares from Apr. 2021 to Apr. 2022 .


HAVN Life Sciences Shares Outstanding (EOP) Historical Data

The historical data trend for HAVN Life Sciences's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAVN Life Sciences Shares Outstanding (EOP) Chart

HAVN Life Sciences Annual Data
Trend Apr20 Apr21 Apr22
Shares Outstanding (EOP)
2.23 3.59 5.09

HAVN Life Sciences Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.25 5.09 5.68 8.47 14.74

Competitive Comparison of HAVN Life Sciences's Shares Outstanding (EOP)

For the Biotechnology subindustry, HAVN Life Sciences's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HAVN Life Sciences's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HAVN Life Sciences's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where HAVN Life Sciences's Shares Outstanding (EOP) falls into.



HAVN Life Sciences Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


HAVN Life Sciences  (XCNQ:HAVN) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


HAVN Life Sciences Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of HAVN Life Sciences's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


HAVN Life Sciences (XCNQ:HAVN) Business Description

Traded in Other Exchanges
Address
605 - 130 Brew Street, Port Moody, BC, CAN, V3H 0E3
HAVN Life Sciences Inc is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, it offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.

HAVN Life Sciences (XCNQ:HAVN) Headlines

No Headlines